Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23246022 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Docetaxel in Node Positive Adjuvant Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: 5-fluorouracil;   Drug: Doxorubicin;   Drug: Cyclophosphamide

Indicates status has not been verified in more than two years